ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Accepts BrainStorm’s NurOwn IND Application for Progressive Multiple Sclerosis
December 19, 2018BrainStorm Cell Therapeutics announced the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application to..... -
Eiger Announces FDA Acceptance of IND Application for Lonafarnib
December 05, 2018Eiger BioPharmaceuticals announced the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for lonafarnib.... -
FDA Accepts BeyondSpring IND Application for Plinabulin for the Prevention of Chemotherapy-Induced N
January 25, 2017BeyondSpring Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's Investigational New Drug (IND) application to initiate Phase 2 / 3 trials for its innovative lead asset, Plinabulin.
Pharma Sources Insight January 2025
